microRNAs as cancer therapeutics: A step closer to clinical application

被引:109
作者
Ivkovic, Tina Catela [1 ,2 ]
Voss, Gjendine [1 ]
Cornelia, Helena [1 ]
Ceder, Yvonne [1 ]
机构
[1] Lund Univ, Dept Lab Med, Div Translat Canc Res, Lund, Sweden
[2] Rudjer Boskovic Inst, Lab Personalized Med, Div Mol Med, Zagreb, Croatia
基金
瑞典研究理事会;
关键词
Metastases; Therapy resistance; Drug delivery; miR-34a; miR-15/16; miR-155; MESENCHYMAL TRANSITION; PROSTATE-CANCER; TARGETED DELIVERY; NONCODING RNAS; BREAST-CANCER; MOUSE MODEL; TUMOR; CELLS; EXPRESSION; THERAPY;
D O I
10.1016/j.canlet.2017.04.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
During the last decades, basic and translational research has enabled great improvements in the clinical management of cancer. However, scarcity of complete remission and many drug-induced toxicities are still a major problem in the clinics. Recently, microRNAs (miRNAs) have emerged as promising therapeutic targets due to their involvement in cancer development and progression. Their extraordinary regulatory potential, which enables regulation of entire signalling networks within the cells, makes them an interesting tool for the development of cancer therapeutics. In this review we will focus on miRNAs with experimentally proven therapeutic potential, and discuss recent advances in the technical development and clinical evaluation of miRNA-based therapeutic agents. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:113 / 122
页数:10
相关论文
共 119 条
[1]   MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth [J].
Aakula, Anna ;
Leivonen, Suvi-Katri ;
Hintsanen, Petteri ;
Aittokallio, Tero ;
Ceder, Yvonne ;
Borresen-Dale, Anne-Lise ;
Perala, Merja ;
Ostling, Paivi ;
Kallioniemi, Olli .
MOLECULAR ONCOLOGY, 2015, 9 (07) :1287-1300
[2]   The tumor-suppressive and potential therapeutic functions of miR-34a in epithelial carcinomas [J].
Adams, Brian D. ;
Parsons, Christine ;
Slack, Frank J. .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2016, 20 (06) :737-753
[3]   Circulating miR-200c and miR-141 and outcomes in patients with breast cancer [J].
Antolin, Silvia ;
Calvo, Lourdes ;
Blanco-Calvo, Moises ;
Paz Santiago, Maria ;
Jose Lorenzo-Patino, Maria ;
Haz-Conde, Mar ;
Santamarina, Isabel ;
Figueroa, Angelica ;
Miguel Anton-Aparicio, Luis ;
Valladares-Ayerbes, Manuel .
BMC CANCER, 2015, 15
[4]   Nanoparticle-based therapy in an in vivo microRNA-155 (miR-155)-dependent mouse model of lymphoma [J].
Babar, Imran A. ;
Cheng, Christopher J. ;
Booth, Carmen J. ;
Liang, Xianping ;
Weidhaas, Joanne B. ;
Saltzman, W. Mark ;
Slack, Frank J. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (26) :E1695-E1704
[5]  
Bader Andreas G., 2012, Frontiers in Genetics, V3, P120, DOI 10.3389/fgene.2012.00120
[6]   miR-34a and miR-15a/16 are co-regulated in non-small cell lung cancer and control cell cycle progression in a synergistic and Rb-dependent manner [J].
Bandi, Nora ;
Vassella, Erik .
MOLECULAR CANCER, 2011, 10
[7]   miR-15a and miR-16 Are Implicated in Cell Cycle Regulation in a Rb-Dependent Manner and Are Frequently Deleted or Down-regulated in Non-Small Cell Lung Cancer [J].
Bandi, Nora ;
Zbinden, Samuel ;
Gugger, Mathias ;
Arnold, Marlene ;
Kocher, Verena ;
Hasan, Lara ;
Kappeler, Andreas ;
Brunner, Thomas ;
Vassella, Erik .
CANCER RESEARCH, 2009, 69 (13) :5553-5559
[8]   Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors [J].
Beg, Muhammad S. ;
Brenner, Andrew J. ;
Sachdev, Jasgit ;
Borad, Mitesh ;
Kang, Yoon-Koo ;
Stoudemire, Jay ;
Smith, Susan ;
Bader, Andreas G. ;
Kim, Sinil ;
Hong, David S. .
INVESTIGATIONAL NEW DRUGS, 2017, 35 (02) :180-188
[9]   Immune responses to gene therapy vectors: influence on vector function and effector mechanisms [J].
Bessis, N ;
GarciaCozar, FJ ;
Boissier, MC .
GENE THERAPY, 2004, 11 (Suppl 1) :S10-S17
[10]   MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer [J].
Bhattacharya, Resham ;
Nicoloso, Milena ;
Arvizo, Rochelle ;
Wang, Enfeng ;
Cortez, Angelica ;
Rossi, Simona ;
Calin, George A. ;
Mukherjee, Priyabrata .
CANCER RESEARCH, 2009, 69 (23) :9090-9095